That R&D takes place not only at big pharma companies—household names ... less well-known but no less heroic biosciences startups, such as Vivek Ramaswamy’s Roivant Sciences, which has brought ...

Elon Musk and fellow entrepreneur Vivek Ramaswamy's committee to slash government ... a failed presidential candidate and Big Pharma moneymaker, to lead his government spending advisory board.

Axovant is founded and financed by Roivant and its CEO Vivek Ramaswamy, whose central strategy is to buy drugs that have been abandoned or shelved by big pharma and successfully bring them to market.

Switzerland-based biopharma start-up Enzyvant has gained a double fast track status from the FDA for its new rare disease candidate RVT-802. The investigational tissue-based therapy is for the ...

In Roivant, Pfizer has a partner with "a proven track record in late-stage inflammation and immunology drug development," said the big ... by entrepreneur Vivek Ramaswamy – which specialises ...

Polis tagged both Elon Musk and Vivek Ramaswamy ... but what I’m most optimistic about is taking on big pharma and the corporate ag oligopoly to improve our health,” Polis posted as part ...

Big changes may be in the offing at the Consumer ... to defund it either,” wrote GOP Ohio gubernatorial candidate Vivek Ramaswamy who recently stepped down from his role at DOGE to focus on ...

The Ronald Reagan dinner is prestigious and was headlined this year by Bishop Strickland, and my personal favorite, Vivek Ramaswamy ... through advertising on legacy media outlets. Big Tech and Big ...

He's worth about $1 billion. So what exactly is Vivek Ramaswamy’s business background and how did he get rich so young? A ...

Vivek Ramaswamy, the Cincinnati-born biotech entrepreneur who departed the Department of Government Efficiency (DOGE) initiative on President Donald Trump's first day, is set to make a big ...